Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
Findings May Potentially Lead to New Approach to Stroke Treatment
BOCA RATON, Fla., July 30 /PRNewswire-USNewswire/ -- When minimally invasive endovascular (through the vessel) therapy made its debut two decades ago, stroke care underwent a major shift as the "window of treatmen...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
INDIANAPOLIS, July 22 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today during a lease signing event that
it has become the first tenant of New York City's new Alexandria Center for Science and Technology at East River Science Park, a development that
New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
HARRISBURG, Pa., June 25 /PRNewswire/ -- In a revolutionary healthcare finding, a peer-reviewed clinical study published in the British Journal of Nutrition (a Cambridge University Journal), clearly shows that
Prebiotics reduce cholesterol and triglycerides, control body weight, and increase...
Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
Therapy targets folate receptors found on cancer cells otherwise resistant to standard chemo
ZION, Ill., June 17 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center, a leading provider of innovative cancer care for patients living wi...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
New LifeShirt(R) to Address Data and Usability Gaps in Remote Patient Monitoring Market
VENTURA, Calif., June 8 /PRNewswire/ -- VivoMetrics, Inc., a leading innovator in remote patient monitoring (RPM), announced today the first complete prototype of their next generation LifeShirt for the re...
Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
Studies Advocate Blood Conservation and Appropriate Indicators for Transfusion
IRVINE, Calif., June 8 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that
two new studies - ...
Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
Data from Phase II/III Study Presented at Heart Failure Congress 2009 Demonstrate Promising Safety and Efficacy Results for Relaxin
SAN MATEO¿ Calif.¿ June 1 /PRNewswire/ -- Corthera Inc. today announced that
the results and additional statistical analyses conducted from Pre-RELAX-AHF, the Phase...
Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
A Drug's Activity Against Anaerobes is the Leading Attribute in Antibiotic Selection, According to a New Report from AMR and Decision Resources
MALVERN, Pa. and WALTHAM, Mass. , May 27 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that
surveyed physicians will...
FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
PARSIPPANY, N.J., May 11 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that
the U.S. Food and Drug Administration ("FDA") accepted the Company's Investigational New Drug ("IND") application for the us...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for resea...
Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
Identifies potential clinical trial strategies for personalized approach to cancer treatment
SEATTLE, April 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC), presented data from a preclinical study, whic...
Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line
Only 39 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources
WALTHAM, Mass., April 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceut...
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) today reported on an NIH-funded, pre-clinical study conducted by independent researchers at the University of Cincinnati entitled IGF-1--Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell ...
New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
Patients on corticosteroids are one-third less likely to need emergency room treatment or hospitalization when also taking statin medications
Study is first in a series to examine factors impacting patient response to asthma medications
FRANKLIN LAKES, N.J., March 14 /PRNewswire-FirstCal...
Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- On the surface, the thick, red, scaly, itchy plaques of psoriasis -- which have been shown to have a significant negative impact on a person's overall quality of life -- may not appear to pose a serious health risk for patients. However, a growing ...
Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss
Unique Case Study of Patient Before & After mTBI Accident
Presentation at American Balance Society, Case Study on Web Site, New Help for Returning Vets
PITTSBURGH, March 4 /PRNewswire/ -- With record numbers of American soldiers returning from Iraq and Afghanistan with brain injuries...
A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
Pfizer's Axitinib Earns Decision Resources' Gold-Standard for Renal Cell Carcinoma in 2012, According to a New Report from Decision Resources
WALTHAM, Mass., Feb. 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare is...
When to Have That Joint Replacement?
Some minority groups wait too long for surgery, study finds
LAS VEGAS, Feb. 25 /PRNewswire-USNewswire/ -- Hispanic and African-American patients tend to have poorer joint function before undergoing hip or knee replacement surgery, according to a new study presented today at the 2009 Annual Me...
New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
Study was conducted with 274 adults with intellectual disabilities currently receiving funding from a state developmental disability agency
WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- The Supports Intensity Scale (SIS) assessment tool can effectively predict funding for people with intelle...
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Proves significance of AHCC for maintaining a healthy immune system
PURCHASE, N.Y., Jan. 6 /PRNewswire/ -- A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that
AHCC (Active Hexose Correlated Compound) ...
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
BASEL, Switzerland, Dec. 10 /PRNewswire/ -- New data being presented at
the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that
(trastuzumab), Avastin (bevacizumab) and oral Xeloda (capecitabine) continue
to offer new and better treatment options for breast cancer patients al...
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
CARLSBAD, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals,
Inc. (Nasdaq: ISIS ) announced today that
OncoGenex Pharmaceuticals, Inc.
provided positive survival results from a randomized Phase 2 clinical trial of
OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm...
New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Posit Science Corporation
researcher, Dan Tinker, presented evidence at the Society for Neuroscience
Annual Conference in Washington, DC this week indicating that
training may benefit Baby Boomers. The computerized brain plasticity-based
Parasites That Live Inside Cells Use Loophole to Thwart Immune System
A study from St. Jude scientists shows how microbes can block nitric
oxide production - a chemical key to the immune system - and offers hints
for fighting bacteria
MEMPHIS, Tenn., Nov. 3 /PRNewswire-USNewswire/ -- St. Jude Children's
Research Hospital scientists have discovered a mechanism ...
New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
- Higher Sustained Virological Response Rates Recognized as Marker of
Treatment Success -
SAN FRANCISCO, Calif., Nov. 1 /PRNewswire/ -- A new,
independently-conducted study being presented at the 59th Annual Meeting of
the American Association for the Study of Liver Diseases (AASLD) shows th...
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
- Study showed no consistent differences in bone mineral density at the
lumbar spine and total hip between Advair Diskus 250/50 (fluticasone
propionate and salmeterol inhalation powder) and salmeterol
- Study provides support for long term use of Advair(R) in patients
NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
Data presented at annual ICAAC/IDSA meeting in Washington, D.C.
WASHINGTON, Oct. 27 /PRNewswire/ -- A novel topical therapy for nail
fungus, NB-002, has demonstrated a new topical approach to healing nail
fungus by penetrating skin pores and diffusing through the skin that
surrounds the en...
PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
- PTC124 Highlighted in Multiple Presentations at North American Cystic
Fibrosis Conference -
SOUTH PLAINFIELD, N.J. and ORLANDO, Fla., Oct. 24 /PRNewswire/ -- PTC
Therapeutics, Inc. (PTC) today announced that
results from a randomized
Phase 2a European study demonstrated that
Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
Despite Widespread Use, Formulary Coverage of Targeted Cancer Therapies is Inconsistent, According to a New Report from Decision Resources
WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
- Data Presented at ACG Annual Scientific Conference -
ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Ironwood Pharmaceuticals
(formerly Microbia) today announced presentation of data from a pair of
preclinical studies delineating the role that
monophosphate (cGMP) plays in al...
Resurgent Health and Medical Announces That Children's Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
Hospital makes proactive choice to elevate hand hygiene measures for patients, staff and visitors
GOLDEN, Colo. and MINNEAPOLIS, Sept. 30 /PRNewswire/ -- Resurgent
Health and Medical, a leader in automated handwashing and sanitizing
technology, announced today that
New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
- Transdermal Estrogen Analyses Continue to Show Benefits of Hormone Therapy Use in Menopausal Women -
MAPLE GROVE, Minn., Sept. 25 /PRNewswire/ -- Upsher-Smith Laboratories,
Inc. today announced that
clinical abstracts featuring Divigel(R)
(estradiol gel) 0.1% were present...
Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
Importance of cleaning floor drains often underestimated in food safety and sanitation protocols
ATLANTA, Sept. 24 /PRNewswire/ -- Recent media coverage of food recalls
and outbreaks has consumers concerned about food safety. As a result of the
increased scrutiny, many f...
Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
BOSTON, Sept. 24 /PRNewswire-FirstCall/ -- Cancer treatment specialists
reported yesterday how new technologies are enabling them to provide
faster, more accurate cancer treatments than was possible with earlier
generations of radiotherapy technology. In presentations given at an
Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia
Most Important Factors Driving Nosocomial Pneumonia Prescribing in Hospitals Are Infectious Disease Consults and ATS/IDSA Guidelines Arlington Medical Resources and Decision Resources Introduce the New Hospital Anti-Infectives Insight Series
MALVERN, Penn. and WALTHAM, Mas...
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
- BENEFIT is first and only prospectively planned 5-year study to show long lasting benefit of early treatment -
MONTREAL, Sept. 20 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals
announced today that
new data from its BENEFIT (BEtaseron in Newly Emerging
multiple sclerosis For...
Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
PURCHASE, N.Y., Sept. 11 /PRNewswire-FirstCall/ -- Nutrition 21, Inc.
(Nasdaq: NXXI ), the developer and marketer of nutritional supplements under
the Iceland Health Chromax(R), and Diabetes Essentials(TM) brands that
consumers manage blood sugar levels, improve cardiovascular health, en...
Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
Proves promising for individuals living with West Nile Virus and populations susceptible such as the elderly or immune compromised
PURCHASE, N.Y., Sept. 9 /PRNewswire/ -- A recently completed study from
researchers at Colorado State University supported by the Division of
Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
This analysis showed that
Multaq(R) (dronedarone) decreased the risk of
stroke by 34% in patient with atrial fibrillation or atrial flutter already adequately treated by antithrombotic therapy
BRIDGEWATER, N.J., Sept. 3 /PRNewswire-FirstCall/ -- The results of a
post-hoc analysis ...
Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
PARIS, September 3 /PRNewswire-FirstCall/ --
- This Analysis Showed That
Multaq(R) (Dronedarone) Decreased the Risk
of Stroke by 34% in Patients With Atrial Fibrillation or Atrial Flutter
Already Adequately Treated by Antithrombotic Therapy
The results of a post-hoc analysis of the data fr...